Literature DB >> 18321822

Meningeal relapse by follicular lymphoma as a single mass.

Víctor Moreno García1, Andrés Redondo, Amelia Fernández Zubillaga, Manuel González-Barón.   

Abstract

Follicular lymphoma is the second most common lymphoma throughout the world. Its course is usually indolent. Affection of Central Nervous System by a follicular lymphoma is usually as primary disease, and secondary affection is usually due to high-grade transformation. In this case-report we describe a young patient who presented a follicular lymphoma which secondary affected the central nervous system without high grade transformation.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18321822     DOI： 10.1007/s12094-008-0177-x

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


  9 in total

1.  Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Authors:  V Boehme; S Zeynalova; M Kloess; M Loeffler; U Kaiser; M Pfreundschuh; N Schmitz
Journal:  Ann Oncol       Date:  2006-10-03       Impact factor: 32.976

Review 2.  Secondary central nervous system involvement by follicular lymphoma: case report and review of the literature.

Authors:  N L Grupka; J Seinfeld; J Ryder; K O Lillehei; B K Kleinschmidt-Demasters
Journal:  Surg Neurol       Date:  2006-06

3.  The natural history of initially untreated low-grade non-Hodgkin's lymphomas.

Authors:  S J Horning; S A Rosenberg
Journal:  N Engl J Med       Date:  1984-12-06       Impact factor: 91.245

4.  Central nervous system involvement in indolent lymphomas.

Authors:  G Spectre; A Gural; G Amir; A Lossos; T Siegal; O Paltiel
Journal:  Ann Oncol       Date:  2005-01-10       Impact factor: 32.976

5.  Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model.

Authors:  A Hollender; S Kvaloy; O Nome; E Skovlund; K Lote; H Holte
Journal:  Ann Oncol       Date:  2002-07       Impact factor: 32.976

6.  New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.

Authors:  J O Armitage; D D Weisenburger
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

7.  High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.

Authors:  Upendra Hegde; Armando Filie; Richard F Little; John E Janik; Nicole Grant; Seth M Steinberg; Kieron Dunleavy; Elaine S Jaffe; Andrea Abati; Maryalice Stetler-Stevenson; Wyndham H Wilson
Journal:  Blood       Date:  2004-09-09       Impact factor: 22.113

Review 8.  Central nervous system lymphoma.

Authors:  Andrew Lister; Lauren E Abrey; John T Sandlund
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2002

9.  Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis.

Authors:  J P Litam; F Cabanillas; T L Smith; G P Bodey; E J Freireich
Journal:  Blood       Date:  1979-12       Impact factor: 22.113
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.